A new app to access naloxone, the life-saving medicine to prevent an opioid overdose, is launched in Somerset today on International Overdose Awareness Day [31 August]. The app, which is supported by University of Bristol research, is the first-of-its kind in England.
ENT (ear, nose and throat) problems relating to the ears, hearing and upper respiratory system, were found to be more common in young children with a subsequent diagnosis of autism or who demonstrated high levels of autism traits, finds a new study from researchers at the University of Bristol and Aston University published today [24 April] in BMJ Open.
A medical student who recently broke two British weightlifting records has been picked to represent England at the Commonwealth Championships.
Consumers value their personal data including the one collected by retail stores, service providers and loyalty schemes. The University of Bristol-led research, published in PLOS ONE, found 96% of people would protect their personal data from being shared by retailers and online services for commercial gain if they had a choice.
A student who raised £185,000 doing all 102 Olympic sports over the 17 days of the Tokyo Games today received her MBE from Princess Anne.
People with type 2 diabetes who took part in a diet-assisted weight loss trial, showed differences across a wide range of potential biomarkers of metabolic health one year later, according to the results of a new study.
Of the more than 1.8 million adults in England with a recorded diagnosis of being overweight or obesity, only three percent are referred to publicly funded weight management programmes, according to a new University of Bristol-led study published today [28 September] in PLOS Medicine.
University of Bristol-led research comparing the effectiveness and safety of different types of moisturiser for childhood eczema has won the Royal College of General Practitioners (RCGP) Research Paper of the Year (RPY) Award 2022.
A simple but revolutionary test to improve early detection for dementia and Alzheimer’s disease could soon be helping patients and their families, thanks to a significant £1.5 million funding boost awarded to the universities of Bath and Bristol.
A first-of-its kind hormone replacement therapy that more closely replicates the natural circadian and ultradian rhythms of our hormones has shown to improve symptoms in patients with adrenal conditions. Results from the University of Bristol-led clinical trial are published today [20 October] in the Journal of Internal Medicine.
